浅析肺泡表面活性物质对新生儿急性呼吸窘迫征氧合功能的影响  

The Influence of Pulmonary surfactant on neonatal acute respiratory distress syndrome oxygenation function

作　　者：冯妍[1] Feng Yan(Pediatrics, Anshan Maternal and Children's Hospital of Liaoning Province, Anshan, Liaoning, 114003,China)

机构地区：[1]辽宁省鞍山市妇儿医院儿科,辽宁鞍山114003

出　　处：《当代医学》2017年第14期28-30,共3页Contemporary Medicine

摘　　要：目的采用肺泡表面活性物质对院内收治的新生儿急性呼吸窘迫征患儿进行医治,以评估肺泡表面活性物质对新生儿急性呼吸窘迫征氧合功能的影响。方法将88例新生儿急性呼吸窘迫征患儿的相关信息进行收集,按照随机原则分为对照组和实验组,每组44例,分别对患儿采用常规治疗和联合使用肺泡表面活性物质的治疗,对治疗后患儿氧合功能的改善情况进行对比,以评估肺泡表面活性物质对新生儿急性呼吸窘迫征氧合功能的影响。结果相比于常规治疗,联合使用肺泡表面活性物质可以显著改善患儿的氧合功能,提高患儿的临床治疗效果,差异有统计学意义(P<0.05)。结论肺泡表面活性物质对于改善新生儿急性呼吸窘迫的效果显著,因此推荐临床使用。Objective To use pulmonary surfactant treatment for patients with nosocomial syndrome admitted to neonatal acute respiratory distress and to evaluate the effect of pulmonary surfactant distress syndrome oxygenation function of neonatal acute respiratory syndrome.Methods The related information of88cases of children with syndrome of neonatal acute respiratory distress were collected and randomly divided into control group and experimental group,each group of44cases were treated by routine treatment and combined use of pulmonary surfactant on children,to compare the improvement of children's oxygenation function after treatment,to evaluate pulmonary distress effect of oxygenation on syndrome of neonatal acute respiratory.Results Compared to the conventional treatment,the combined use of pulmonary surfactant can significantly improve oxygenation function,improve the clinical treatment effect of patients,the difference was statistically significant(P<0.05).Conclusion Pulmonary surfactant to improve the effect of neonatal acute respiratory distress,therefore recommended for clinical use.

关 键 词：新生儿急性呼吸窘迫征 肺泡表面活性物质 氧合功能 

分 类 号：R722.12[医药卫生—儿科]